Axcelon Biopolymers Corporation is located in London, Ontario, and is focused on developing and commercializing innovative medical devices that use the advantages of its Microbial Cellulose (MC) biomaterial platform technology for applications in regenerative medicines and medical devices. The Company has patented processes and nanopolymer technologies to develop new and improved medical devices and deliver enhanced healthcare.